XTAE
CISY
Market cap75mUSD
Jul 09, Last price
2,082.00ILS
1D
-3.61%
1Q
-45.71%
Jan 2017
569.24%
Name
C I Systems Israel Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CI Systems (Israel) Ltd. is a global provider specializing in the development, manufacturing, and distribution of high-precision electro-optical test and measurement solutions. Their comprehensive portfolio encompasses a diverse array of electro-optical test systems, including SWIR, FLIR, and day cameras, alongside specialized equipment for testing lasers, detectors, and boresight alignment. The company also supplies advanced tools such as missile warning system testers, optical alignment systems, and integrating sphere systems. A significant part of their offering includes blackbody radiation sources, available as extended area and cavity models, complemented by RAD motorized target wheels and associated accessories. Furthermore, they provide aperture and wide field of view collimators. Beyond testing equipment, CI Systems develops infrared radiometric products, featuring multi-channel, multi-spectral, dual-band fast, and solar-blind imaging radiometers tailored for remote sensing applications. Their extensive product range also covers optical gas imaging solutions, temperature screening cameras, atmospheric transmission measurement systems, spectroradiometers, and circular variable filters. Additionally, the company manufactures optical monitoring equipment, such as noncontact temperature monitors and liquid monitoring systems, specifically designed for wafer and photovoltaic solar cell manufacturing processes. Founded in 1977, CI Systems is headquartered in Migdal HaEmek, Israel, and operates as a subsidiary of CI Technologies Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||